# Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
Canonical URL: https://biopharmsignal.com/news/ALHC/alignment-healthcare-named-to-the-fortune-1000-2026-list-for-second-consecutive-year
Ticker: ALHC
Company: Alignment Healthcare
Source: Alignment Healthcare
Published: 2026-06-25 13:46 EST
Original Source URL: https://ir.alignmenthealth.com
## Summary

The company rises 196 spots to No. 791 on the Fortune 1000 2026 list following continued growth and momentum ORANGE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been named to the Fortune 1000 ® 2026 list for the second consecutive year, rising more than

## Article Body
The company rises 196 spots to No. 791 on the Fortune 1000 2026 list following continued growth and momentum ORANGE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been named to the Fortune 1000 ® 2026 list for the second consecutive year, rising more than
## Recent Company News
- 2026-06-25 13:46 EST — [Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year](https://biopharmsignal.com/news/ALHC/alignment-healthcare-named-to-the-fortune-1000-2026-list-for-second-consecutive-year) — Source: Alignment Healthcare
- 2026-06-25 13:46 EST — [Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report](https://biopharmsignal.com/news/ALHC/alignment-healthcare-shows-how-earlier-coordinated-care-leads-to-better-health-and-fewer-emergencies-in-2025-impact-report) — Source: Alignment Healthcare
- 2026-06-25 13:46 EST — [Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026](https://biopharmsignal.com/news/ALHC/alignment-healthcare-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-2026) — Source: Alignment Healthcare
- 2026-06-25 13:46 EST — [Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality](https://biopharmsignal.com/news/ALHC/alignment-health-plan-recognized-as-one-of-four-medicare-advantage-prescription-drug-plans-in-the-u-s-for-2026-excellence-in-quality) — Source: Alignment Healthcare
- 2026-06-25 13:46 EST — [Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation](https://biopharmsignal.com/news/ALHC/alignment-healthcare-strengthens-leadership-team-to-support-long-term-growth-and-shareholder-value-creation) — Source: Alignment Healthcare
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)